Matches in Nanopublications for { ?s ?p "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP803666.RASEI5ghfbN92OQYsAcdbBUdReU-8mp-eg9C8BkomvLok130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803666.RASEI5ghfbN92OQYsAcdbBUdReU-8mp-eg9C8BkomvLok130_provenance.
- NP803667.RAfG1hD0fuZlJmYLOGvgWZmFVrSPhai1uZV6ut-9iRDOc130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803667.RAfG1hD0fuZlJmYLOGvgWZmFVrSPhai1uZV6ut-9iRDOc130_provenance.
- NP803669.RARqglTn8CNjCb5FAZ8wbGLxse0Ocp7zMuKsJ3pEBvn_s130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803669.RARqglTn8CNjCb5FAZ8wbGLxse0Ocp7zMuKsJ3pEBvn_s130_provenance.
- NP803673.RAW-S4Znux5ft1R7uSLLQQvMsKfRZSEB-b0YJtEgyGQ_4130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803673.RAW-S4Znux5ft1R7uSLLQQvMsKfRZSEB-b0YJtEgyGQ_4130_provenance.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_provenance.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_provenance.